Irish healthcare professionals advocating for patients, promoting awareness of latest psychedelic research, and connecting interested parties and policy makers
BREAKING: European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients
The 100-patient study - which includes those with COPD, atypical Parkinsonism, ALS and MS - is expected to commence in January 2025.
https://t.co/dJOlEgEVf3
Big result here. Baseline expectancy for efficacy of psilocybin-therapy in depression was NOT predictive of actual response to psilocybin therapy. Conversely, expectancy for the SSRI DID predict response to the SSRI.
The European Medicines Agency (@EMA_News) is set to hold a workshop on medical #Psychedelics in April 2024 to establish regulatory guidelines for the development and therapeutic use of psychedelic substances in #Europe.
Find out more.👇
#Healthcare
https://t.co/5tuc7I0myt
Whether in connection with mental health treatments, wellness, or research, psychedelics have become part of our public discourse
Explore the fundamentals of psychedelics & what they may teach us about the mind in our free online course - out now!
✍ https://t.co/0jfENbkaqp
Whether in connection with mental health treatments, wellness, or research, psychedelics have become part of our public discourse
Explore the fundamentals of psychedelics & what they may teach us about the mind in our free online course - out now!
✍ https://t.co/0jfENbkaqp
Ketamine non-inferior to ECT as therapy for treatment-resistant major depression in large open-label randomised study (n=403) @NEJM. https://t.co/ijluHuRMlp
#ketamine#depression
@drugsdotie Will there be front of house drug testing at festivals this year to help people avoid potentially harmful doses of drugs? This model has proven very successful at Boom Festival in Portugal where most people binned pills that contained drugs they did not expect.
“Psychedelic drugs are classified as more dangerous than opiates and cocaine, and this is not morally, medically or economically appropriate” Amazing speech from @CrispinBlunt on rescheduling #psilocybin at the #UKparliament.
The Royal College of Psychiatrists urge Parliament to allow access to psilocybin assisted therapy.
When will this be discussed in Irish parliament?
@DonnellyStephen
@IrishPsychiatry@HSELive
https://t.co/33Y28HfKTq
🌱 Plant an idea. Watch it grow. Announcing The Science of Psychedelics with Dr David Luke, presented by @SeedTalks
🗓️14 June 2023
⏰ 5pm-6:30pm
⏰ 8pm-9:30pm
🎟️➡️ https://t.co/xZYwjFLi6f
An in-depth examination of traditional + modern psychedelics with @drdluke
@LukeJelen@TheBorisLab subconscious material that could then be worked through in psychotherapy. Would be interesting to know which participants were in psychotherapy and which were not. This may explain the large ''placebo'' effect.
@LukeJelen@TheBorisLab There is anecdotal evidence of people finding surgery under general anesthesia to be an event that brought back old psychological trauma. In this study, participants were allowed concurrent psychotherapy. I wonder did the surgery allow them access to more...
@richardludlow@TheBorisLab@TheresaLii subconscious material that could then be worked through in psychotherapy. Did you record which participants were in psychotherapy and which were not? This may explain the large ''placebo'' effect.
@richardludlow@TheBorisLab@TheresaLii There is anecdotal evidence of people finding surgery under general anesthesia to be an event that brought back old psychological trauma. I note from your study that participants were allowed concurrent psychotherapy. I wonder did the surgery allow them access to more...
SPIKED: Stanford Placebo vs Intraop Ketamine Evaluated for Depression. We masked ketamine with surgical anesthesia in depressed patients. Full details now published, peer review pending. Huge antidepressant response in both groups. @TheresaLii 1st auth
https://t.co/o9zdg0WY1Z